NASDAQ:ALXO
ALX Oncology Holdings Inc.
- Stock
Last Close
14.66
17/05 20:00
Market Cap
734.33M
Beta: 1.66
Volume Today
188.72K
Avg: 271.68K
PE Ratio
−4.46
PFCF: −6.91
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
asset turnover | 0.19 - | 0.45 142.63% | 0.00 99.40% | ||||
cash conversion cycle | 29.25 - | -272.97 1,033.09% | -1.36 99.50% | ||||
cash per share | 0.38 - | 0.41 9.14% | 23.49 5,618.48% | 9.02 61.59% | 12.29 36.24% | 4.25 65.42% | |
company equity multiplier | 1.22 - | -38.68 3,272.04% | -3.68 90.49% | -1.88 48.84% | -0.94 49.97% | 1.28 235.77% | |
days of inventory outstanding | |||||||
days of payables outstanding | 135.32 - | 313.77 131.87% | 1.36 99.57% | 3.75K - | |||
days of sales outstanding | 164.58 - | 40.79 75.21% | |||||
dividend yield | 0.00 - | 0.09 - | |||||
ebit per revenue | -6.62 - | -4.00 39.58% | -36.94 823.55% | ||||
ebt per ebit | 1.00 - | 1.00 0.12% | 1.04 4.06% | 1.00 4.12% | 0.97 3.07% | 0.94 2.49% | |
effective tax rate | -0.00 - | -0.00 46.17% | -0.01 199.25% | 0.00 104.75% | -0.00 306.15% | ||
enterprise value multiple | -49.06 - | -34.91 28.83% | -26.31 24.65% | -6.03 77.08% | -1.46 75.77% | -3.75 156.43% | |
fixed asset turnover | 2.16 - | 5.58 157.93% | 22.73 307.60% | ||||
free cash flow per share | -0.63 - | -0.67 5.48% | -2.07 211.64% | -1.81 12.61% | -2.23 22.94% | -3.06 37.49% | |
gross profit margin | 0.09 - | 0.09 0.49% | 0.09 0.42% | ||||
interest coverage | -913.48 - | -53.84 94.11% | -6.43K 11,838.13% | 29.23 100.45% | -108.80 472.25% | ||
inventory turnover | |||||||
long term debt to capitalization | 1.05 - | -0.03 - | 0.05 262.78% | ||||
net income per ebt | 1.00 - | 1.00 0.15% | 1.01 0.35% | 1.00 0.55% | 1.00 0.08% | 1 0.05% | |
net profit margin | -6.64 - | -4.01 39.60% | -38.70 864.46% | ||||
operating cash flow per share | -0.60 - | -0.65 8.03% | -2.07 219.10% | -1.69 18.43% | -2.19 29.76% | -3.03 38.33% | |
operating cycle | 164.58 - | 40.79 75.21% | |||||
operating profit margin | -6.62 - | -4.00 39.58% | -36.94 823.55% | ||||
payables turnover | 2.70 - | 1.16 56.87% | 268.75 23,002.64% | 0.10 - | |||
pretax profit margin | -6.62 - | -4.01 39.51% | -38.49 861.08% | ||||
price fair value | 71.93 - | -2.39K 3,417.03% | -13.44 99.44% | -4.29 68.10% | -1.41 67.14% | 3.37 339.41% | |
receivables turnover | 2.22 - | 8.95 303.45% | |||||
return on assets | -1.23 - | -1.80 46.55% | -0.10 94.18% | -0.22 109.29% | -0.40 83.52% | -0.66 64.55% | |
return on capital employed | -1.47 - | -3.37 128.82% | -0.10 96.99% | -0.23 125.43% | -0.46 100.07% | -0.82 79.94% | |
return on equity | -1.50 - | 69.72 4,748.58% | 0.39 99.45% | 0.41 7.07% | 0.38 8.18% | -0.85 323.41% | |
total debt to capitalization | 1.05 - | -0.00 - | -0.03 797.92% | 0.06 268.58% |
All numbers in USD (except ratios and percentages)